NCT02832063: A trial that was reported late by AOBiome LLC
This trial has reported, although it was 730 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02832063 |
|---|---|
| Title | A Randomized, Double Blinded, Phase IIb/III, Decentralized Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Participants With Mild to Moderate Acne Vulgaris |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Aug. 31, 2016 |
| Completion date | July 19, 2017 |
| Required reporting date | July 19, 2020, midnight |
| Actual reporting date | July 19, 2022 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 730 |